RESUMO
INTRODUCTION:Uterine leiomyoma occurs with broad range of 20-50% among reproductive aged women. It takessecond place of all women’s genital diseases that cause abnormal menstrual bleeding. Leiomyomadependent surgical frequency such as hysterectomy is around up to 80, 6%. Lately uterine fibroidembolization treatment is highly effective, less painful, and more rapid recovery, most importantlykeeping organ while maintaining the reproductivity, is successfully entered in practice. We successfullyperformed 40 cases first time in Mongolia and 8 of them conceived naturally after treatment.GOAL:To determine if arterial embolization in women with uterine fibroids (leiomyomata) is an effectivemethod to keep their reproductive organ intact.OBJECTIVES:• To study pregnancy cases in women who had uterine fibroid embolization• To monitor and determine the features of course of pregnancy and childbirth.• To evaluate uterine fibroids.MATERIALS AND METHODS:The study was conducted in 2009-2012. A total of forty women between 23-50 years of age,diagnosed with symptomatic uterine fibroid that received embolization treatment of dominatingarterial blood vessel feeding the uterine fibroids were involved in the study. Eight of the forty womenwho conceived naturally were selected for the study. The study focused on monitoring the course oftheir pregnancy and delivery and its outcome.RESULTS:Among 40 women who underwent bilateral uterine artery embolization, 31 (75.5%) were seeking tobecome pregnant, and 8 of the 31 (25, 8%) became pregnant, four having been nulliparous. Onepatient had two pregnancies. All 8 pregnancies were spontaneous. The mean time from embolizationto conception was 12±3, 5 months (range, 6-27 months). Three medical terminations occurred. Theother 5 pregnancies went to term; one pregnancy had to be terminated pre-term due to placentapraevia. 60% experienced threatened abortion and 1 case with advanced age mother complicatedwith mild preeclampsia. 62,5% of the women’s pregnancy ended with childbirth, of which one woman(20%) had vaginal delivery and the remaining four pregnancies (80%) ended with C-section. On anaverage, post-treated uterine fibroids decreased in volume by 94% in comparison to pre-treateduterine fibroids in the patients who became pregnant. All of the neonates were healthy with Apgarscores greater than8. The mean weight of the neonates was 3,189± 200 g (range, 2,100–3,800 g). One neonate waspreterm due to placenta praevia (2,100 g).CONCLUSION:1. Of the forty women that received arterial embolization treatment with uterine fibroid, thirty one(75, 5%) women desired to keep their uterine for further reproduction, of which eight women (25,8% of the patients) between the ages of 23-42 years (mean age=35) conceived naturally. Arterialembolization to treat women with uterine fibroids is an effective method for women who wish to keeptheir reproductive organ intact to conceive and reproduce.2. 60 percent of the women who conceived experienced threatened abortion and 20 percent of thewomen’s pregnancy had to be terminated pre-term due to placenta praevia. 62,5 percent of thewomen’s pregnancy ended with childbirth, of which one woman (20%) had vaginal delivery and theremaining four pregnancies (80%) ended with C-section.3. On an average, post-treated uterine fibroids decreased in volume by 94% in comparison to pretreateduterine fibroids.
RESUMO
The aim of this study was to evaluate the safety, efficacy and outcome of ethanol sclerotherapy for uterine myomata. This is a series of 20 patients (aged 20 to 40 years) with symptomatic uterine myomata submitted to ethanol sclerotherapy. The procedure was performed under sedation and guided by transvaginal ultrasound. The patients were followed clinically and ultrasonically (transvaginal sonography and color Doppler evaluation) one month and six months after treatment. The frequency of symptoms, intratumoral color flow mapping and tumoral size were analyzed. Chi-square and Mann-Whitney tests were used at a 5% level of significance. Postprocedure complications were not observed. A significant relief of dysmenorrhea was observed with one and six months and the frequency of pelvic pain and menorrhagia was significantly reduced with six months. A significant reduction of tumoral size was observed, from 89,4 cm3 (inicial volume) to 73,5 cm3 e 69,9 cm3 (one and six months, respectively). The frequency of intratumoral high blood flow was 80% before and 15% and 20% one and six months after the procedure (p=0,0001). It can be concluded that these preliminary results indicate that transvaginal ultrasound-guided ethanol sclerotherapy can be an effective treatment for uterine myomas when conservative management is preferable. Patient satisfaction was high and the procedure might become an accepted option for the treatment of uterine myomata.
O estudo avaliou a segurança, eficácia e resultados da técnica de alcoolização para tratamento da miomatose uterina. Analisou-se uma série de 20 pacientes (idade variando entre 20 e 40 anos) submetidas a alcoolização para tratamento de miomatose uterina sintomática. O procedimento foi realizado sob anestesia geral, guiado por ultra-sonografia transvaginal. Realizou-se seguimento clínico e ultra-sonográfico (ultra-sonografia transvaginal e doppler colorido) com um e seis meses depois do tratamento. Analisaram-se os parâmetros: frequência de sintomas, mapa vascular (doppler) e tamanho da tumoração. Utilizaram-se os testes do qui-quadrado e Mann-Whitney. Significância p 0,05. Não ocorreram complicações depois do procedimento. Observou-se alívio significativo da dismenorréia com um e seis meses e a frequência de dor pélvica e hipermenorragia reduziu-se significativamente com seis meses. Encontrou-se ainda uma significativa redução do tamanho tumoral, de 89,3cm³ (volume inicial) para 73,5cm³ e 69,9cm³ (um e seis meses, respectivamente). A frequência de padrão de alto fluxo intra-tumroal foi de 80% antes e 15% e 20% um e seis meses depois do procedimento (p=0,0001). Conclui-se que estes resultados preliminares indicam que a alcoolização guiada por ultra-sonografia pode constituir uma opção terapêutica efetiva para o tratamento conservador de pacientes com miomas uterinos. O grau de satisfação das pacientes foi elevado e o procedimento pode vir a se tornar uma opção aceita para o tratamento da miomatose uterina.
RESUMO
Since hysterectomy using laparoscopy has been first reported in 1989, various techniques for laparoscopic hysterectomy were developed. However, complications during hysterectomy still remained and many clinicians assert that huge uterine masses should be performed with laparotomy for safety. We have performed CISH for benign uterine disease such as uterine leiomyomata, PID, chronic pelvic pain, DUB and adenomyosis, etc since 1993. This report is to evalute the clinical efficacy and the feasibility of the CISH for huge uterine masses, which include 20 patients who underwent CISH with huge uterine leiomyomata(more than 250 gm and /or 14 gestational size) between June 1995 and May 1996 in Chung-Ang University Pil-Dong Hospital. No laser, monopolar and stapling cutting devices were used. All of the hysterectomy procedures were performed in the classic manner with grasping forceps, scissors, ligatures, and sutures. We excluded the patients who had cervical neoplasia, or who wanted to have total removal of the uterus in this study. The results were as follows. 1) The age of patients were ranged from 37 to 50 years, and the mean age was 43.78+/-3.8 years. 2) The parity distribution of patients were ranged from 0 to 4, the mean was 1.93+/-0.9. 3) The mean operative time was 171.78+/-36.5minutes, ranged from 130 to 240 minutes. 4) The mean estimated blood loss(EBL) was 223.8+/-206.7cc, ranged from 40 to 700cc 5) The mean uterine weight was 345.9+/-87.3gm, ranged from 256 to 625.7gm 6) There was no major complications and a few minor complication. No procedure was converted to laparotomy. This report suggests that the CISH technique for benign huge uterine leiomyomata is feasible, safer technique, and associated with significantly low morbidity and no major complication.